These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7961157)

  • 21. [The future of antifungal agents. Non azole antifungal agents].
    Maesaki S; Hossain MA; Sasaki E; Hashiguchi K; Higashiyama Y; Yoshitsugu Y; Tomono K; Tashiro T; Kohno S
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(3):157-61. PubMed ID: 10423510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilofungin inhibition of (1-3)-beta-glucan synthase: the lipophilic side chain is essential for inhibition of enzyme activity.
    Taft CS; Selitrennikoff CP
    J Antibiot (Tokyo); 1990 Apr; 43(4):433-7. PubMed ID: 2141016
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
    Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological properties.
    Fujie A; Iwamoto T; Muramatsu H; Okudaira T; Nitta K; Nakanishi T; Sakamoto K; Hori Y; Hino M; Hashimoto S; Okuhara M
    J Antibiot (Tokyo); 2000 Sep; 53(9):912-9. PubMed ID: 11099224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice.
    Maesaki S; Hossain MA; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1728-30. PubMed ID: 10817741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro and In Vivo Evaluation of Small Cationic Abiotic Lipopeptides as Novel Antifungal Agents.
    Lohan S; Monga J; Chauhan CS; Bisht GS
    Chem Biol Drug Des; 2015 Oct; 86(4):829-36. PubMed ID: 25777475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis.
    Müller FM; Kurzai O; Hacker J; Frosch M; Mühlschlegel F
    J Antimicrob Chemother; 2001 Nov; 48(5):713-5. PubMed ID: 11679561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-beta-D-glucan synthase.
    Tang J; Parr TR
    Antimicrob Agents Chemother; 1991 Jan; 35(1):99-103. PubMed ID: 1826595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
    Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
    J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FR227673 and FR190293, novel antifungal lipopeptides from Chalara sp. No. 22210 and tolypocladium parasiticum No. 16616.
    Kanasaki R; Kobayashi M; Fujine K; Sato I; Hashimoto M; Takase S; Tsurumi Y; Fujie A; Hino M; Hashimoto S; Hori Y
    J Antibiot (Tokyo); 2006 Mar; 59(3):158-67. PubMed ID: 16724456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.
    Hall GS; Myles C; Pratt KJ; Washington JA
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1331-5. PubMed ID: 3058017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micafungin: a new echinocandin.
    Chandrasekar PH; Sobel JD
    Clin Infect Dis; 2006 Apr; 42(8):1171-8. PubMed ID: 16575738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FR220897 and FR220899, novel antifungal lipopeptides from Coleophoma empetri no. 14573.
    Kanasaki R; Abe F; Kobayashi M; Katsuoka M; Hashimoto M; Takase S; Tsurumi Y; Fujie A; Hino M; Hashimoto S; Hori Y
    J Antibiot (Tokyo); 2006 Mar; 59(3):149-57. PubMed ID: 16724455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic colisporifungin and linear cavinafungins, antifungal lipopeptides isolated from Colispora cavincola.
    Ortíz-López FJ; Monteiro MC; González-Menéndez V; Tormo JR; Genilloud O; Bills GF; Vicente F; Zhang C; Roemer T; Singh SB; Reyes F
    J Nat Prod; 2015 Mar; 78(3):468-75. PubMed ID: 25636062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.
    Mikamo H; Sato Y; Tamaya T
    J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel echinocandin antifungals. Part 2: Optimization of the side chain of the natural product FR901379. Discovery of micafungin.
    Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
    Bioorg Med Chem Lett; 2008 May; 18(9):2886-90. PubMed ID: 18424132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired resistance to echinocandins in Candida albicans: case report and review.
    Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
    J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
    Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.
    Jacobsen MD; Whyte JA; Odds FC
    Antimicrob Agents Chemother; 2007 May; 51(5):1882-4. PubMed ID: 17307974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.